Description
Identification of therapeutically relevant gene mutations for Cancer
Oncquer Germline Mutation Specific Test (MST)
Identification of therapeutically relevant gene mutations for Cancer
TAT:
Specimen Type:
Genomics Single Test
Other Tests
-
264%
ONCQUER(TM) AML COMBO PANEL
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
ONCQUER(TM) AML COMBO PANEL
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
OncQuer TM Myeloid Panel (1-3 markers)
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Myeloid Panel (1-3 markers)
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
- 263%
-
238%
Clinical Exome Test
multi gene panel. Gene list will be shared on request
Reviews
There are no reviews yet.